Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions – Biogen

By Phoenix Peptide Labs / November 24, 2025

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions Biogen

Post Views: 38

Assistant professor receives NIH grant to improve preservation and storage of peptide and protein-based drugs – Kennesaw State University

Redefining peptide chemistry beyond accumulating analogues – Nature

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Explore our high-purity research compounds designed for laboratory studies in metabolic health, NAD⁺ pathways, and cellular energy regulation.

Facebook-f Twitter Instagram

Information

Research Chemicals
Research Updates
Blogs
COAs
Made In The USA
Contact
Affiliate Portal

Legal

Terms
Privacy
Medical Disclaimer
Compounding Disclosure
Scope of Practice
Accessibility
Return Policy

Contact Info

914-357-0174
contact@phoenixpeptidelabs.com
United States

Not for medical emergencies — Call 911
Services available in all 50 U.S. states where providers are licensed.

Research Use Only
Compounded in authorized US Pharmacies.
Made in USA

21+ Only
By accessing this site you confirm you are 21 years or older.

View Third-Party COAs

Research Chemicals
Peptides by Condition
Research Updates
Blogs
COAs
Calculator
Contact

Added to cart

Your Cart Is Empty

Check out our shop to see what's available

Cart Total: Total$0.00

Your cart is empty. Shop now →